PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU64PM8

Delayed Deutsche Boerse AG 13:00:49 26/06/2024 BST
20.8 EUR +0.82% Intraday chart for PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month+20.36%
1 month+19.25%
Date Price Change
26/06/24 20.8 +0.82%
25/06/24 20.63 +2.23%
24/06/24 20.18 -2.65%
21/06/24 20.73 +4.49%
20/06/24 19.84 -1.44%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 01:00 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU64PM
ISINDE000VU64PM8
Date issued 09/05/2023
Strike 56.25
Maturity Unlimited
Parity 1 : 1
Emission price 16.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 26.36
Lowest since issue 7.82
Spread 0.08
Spread %0.38%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.67 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.07%
Consensus